Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease (Q44673201)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mark T Cahill

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sandra S Stinnett

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sharon Fekrat

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1136-1150

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia in retinal artery and retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Retinal Vein Occlusion and Transient Monocular Visual Loss Associated With Hyperhomocystinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Ocular venous occlusion and hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Ocular venous occlusion and hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma total homocysteine and retinal vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia: a risk factor for central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine: a risk factor for retinal venous occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Thermolabile MTHFR genotype and retinal vascular occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Primary, Secondary, and Meta-Analysis of Research

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Accumulating evidence from independent studies: what we can win and what we can lose

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Methionine metabolism in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Impaired homocysteine metabolism and atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Sex-related differences in methionine metabolism and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Gender differences and other determinants of the rise in plasma homocysteine after l-methionine loading

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Effective homocysteine metabolism may protect South African blacks against coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Activation of Hageman Factor by L-Homocystine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The oxidant stress of hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid — additional mechanisms in homocysteine induced endothelial damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine in the acute and convalescent phases after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

An alternative view of homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Trends in serum folate after food fortification.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Familial thrombophilia and retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Identifiers

10.1016/S0002-9394(03)00571-3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673201&oldid=2031303878"